Evidence map›Paper›PMID 32830900›Full record

ArticleJournal of magnetic resonance imaging : JMRI2021

7T MR Safety.

Andrew J Fagan, Andreas K Bitz, Isabella M Björkman-Burtscher, Christopher M Collins, Vera Kimbrell, Alexander J E Raaijmakers, ISMRM Safety Committee

Open access · greenAbstract read
In one paragraph

Article in Journal of magnetic resonance imaging : JMRI, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. MRI and Implant Safety at Low-Field and Ultralow-Field Strengths.Journal of magnetic resonance imaging : JMRI · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Reduction of radiofrequency induced implant heating via flexible metasurface shielding at 7 T.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Andrew J FaganDepartment of Radiology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-5528-9732
Andreas K BitzFaculty of Electrical Engineering and Information Technology, FH Aachen - University of Applied Sciences, Aachen, Germany.
Isabella M Björkman-BurtscherDepartment of Radiology, University of Gothenburg, Sahlgrenska Academy, Sahlgrenska University Hospital, Gothenburg, Sweden.
Christopher M CollinsCenter for Advanced Imaging Innovation and Research, NYU Langone Medical Center, New York, New York, USA.
Vera KimbrellDepartment of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alexander J E RaaijmakersDepartment of Radiology, UMC Utrecht, Utrecht, The Netherlands.
ISMRM Safety Committee
Brigham and Women's Hospital · USMayo Clinic · USNYU Langone Health · USRWTH Aachen University · DESahlgrenska University Hospital · SEUtrecht University · NL

Funding

TR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical careP41EB017183 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Christopher M Collins · 2014 to 2026
$19.3M
NIBIB NIH HHS P41 EB017183
6 · The paper itself

Abstract

Magnetic resonance imaging and spectroscopy (MRI/MRS) at 7T represents an exciting advance in MR technology, with intriguing possibilities to enhance image spatial, spectral, and contrast resolution. To ensure the safe use of this technology while still harnessing its potential, clinical staff and researchers need to be cognizant of some safety concerns arising from the increased magnetic field strength and higher Larmor frequency. The higher static magnetic fields give rise to enhanced transient bioeffects and an increased risk of adverse incidents related to electrically conductive implants. Many technical challenges remain and the continuing rapid pace of development of 7T MRI/MRS is likely to present further challenges to ensuring safety of this technology in the years ahead. The recent regulatory clearance for clinical diagnostic imaging at 7T will likely increase the installed base of 7T systems, particularly in hospital environments with little prior ultrahigh-field MR experience. Informed risk/benefit analyses will be required, particularly where implant manufacturer-published 7T safety guidelines for implants are unavailable. On behalf of the International Society for Magnetic Resonance in Medicine, the aim of this article is to provide a reference document to assist institutions developing local institutional policies and procedures that are specific to the safe operation of 7T MRI/MRS. Details of current 7T technology and the physics underpinning its functionality are reviewed, with the aim of supporting efforts to expand the use of 7T MRI/MRS in both research and clinical environments. Current gaps in knowledge are also identified, where additional research and development are required. Level of Evidence 5 Technical Efficacy 2 J. MAGN. RESON. IMAGING 2021;53:333-346.

Indexed as

Magnetic FieldsMagnetic Resonance ImagingHumansMagnetic Resonance SpectroscopyPhysics7Tesla MRI/MRS safetyimplantsnumerical simulationsparallel transmissionradiofrequency coilsSAR

Identifiers

PMID32830900
PMCPMC8170917
OpenAlexW3081011734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.